This novel functionality of ORF3a, different from targeting autophagosome-lysosome fusion, is a selective impediment of STING-mediated autophagy, thereby promoting viral proliferation
Nov 15: Patients with ROS1-positive non-small cell lung cancer have a new treatment option after the FDA approved Bristol Myers Squibbs Augtyro (repotrectinib) on Wednesday
"This blocks interactions between melanocytes [the skin cells that produce melanin] and keratinocytes [cells that provide skin structure]." By blocking interactions between the two, dark spots, signs of melasma, and post-acne hyperpigmentation become less pigmentated, creating a clearer, more radiant tone
A doctor will also establish baseline IGF-1 levels and monitor them to ensure they stay in a healthy range personalization might mean adjusting the peptide dose or regimen
non-archive version no longer available